Many of us think of chickenpox as a childhood illness, a harmless rite of passage that fades into memory once the itchy blisters heal. However, what most people don’t realize is that the virus behind ...

EMA accepts for review regulatory application of GSK’s Shingrix new prefilled syringe presentation for prevention of shingles: London, UK Wednesday, January 29, 2025, 13:00 Hrs ...

The antiviral drug valaciclovir (Valtrex), given prophylactically, kept patients with systemic lupus erythematosus (SLE) under treatment with anifrolumab (Saphnelo) from having herpes zoster ...

Prompt medical care is advised. Shingles (herpes zoster) is a viral infection caused by the same virus that causes chickenpox. The virus lies dormant in your body for years after chickenpox resolves.

Hershey Medical Center, Hershey PA. The annual incidence of herpes zoster (HZ; shingles), which is caused by the reactivation of latent varicella zoster virus (VZV), is about 1 million in the US.

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of ...

Varicella-zoster virus (VZV) is a known cause of meningoencephalitis, typically in immunocompromised inpatients. We report a ...

Symptoms of shingles, also known as herpes zoster, include burning or stabbing pain accompanied by a rash of blisters that typically follows a nerve pathway on the body or the face. Up to 50 ...

Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Herpes Zoster (Shingles) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. Report includes ...

These two reports address the effects of varicella-zoster vaccination and varicella vaccination. Richard Whitley, who chaired the data and safety monitoring board for the Shingles Prevention Study ...

Shingles is a funny-sounding name for a seriously painful disease. How painful? That’s hard to put into words. Printable ones ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...